[Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000305:Adrenal Cortex Hormones / Q000096:biosynthesis; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy*; D000324:Adrenocorticotropic Hormone / Q000502:physiology; D000616:Aminoglutethimide / Q000009:adverse effects / Q000627:therapeutic use; D000814:Aniline Compounds / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D002784:Cholesterol / Q000378:metabolism; D002986:Clinical Trials as Topic; D003480:Cushing Syndrome / Q000188:drug therapy*; D003864:Depression, Chemical; D006628:Hirsutism / Q000188:drug therapy*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism; D008190:Lyases / Q000037:antagonists & inhibitors; D011284:Pregnenolone / Q000096:biosynthesis; D011728:Pyridones / Q000627:therapeutic use*; D012636:Secretory Rate
D015065:17-Hydroxycorticosteroids; D000305:Adrenal Cortex Hormones; D000814:Aniline Compounds; D000927:Anticonvulsants; D011728:Pyridones; D000616:Aminoglutethimide; D011284:Pregnenolone; D000324:Adrenocorticotropic Hormone; D002784:Cholesterol; D008190:Lyases; D006854:Hydrocortisone
Etude clinique et biologique d'un inhibiteur de l'hormonosynthèse cortisocurrénale: l'aminoglutéthimide.